People: IDEXX Laboratories Inc (IDXX.O)

IDXX.O on Nasdaq

83.81USD
24 May 2013
Price Change (% chg)

$-0.67 (-0.79%)
Prev Close
$84.48
Open
$84.24
Day's High
$84.27
Day's Low
$83.49
Volume
251,579
Avg. Vol
426,705
52-wk High
$101.18
52-wk Low
$81.31

Search Stocks

Summary

Name Age Since Current Position

Jonathan Ayers

 57 2002 Chairman of the Board, President, Chief Executive Officer

Willard Blanche

 39 2013 Acting Chief Financial Officer, Vice President - Finance

William Brown

 58 2012 Executive Vice President, Chief Scientific Officer

Jeffrey Fiarman

 44 2013 Executive Vice President, General Counsel

Jay Mazelsky

 52 2012 Executive Vice President

Johnny Powers

 51 2012 Executive Vice President

Michael Williams

 45 2012 Executive Vice President

Daniel Meyaard

 55 2009 Corporate Vice President - Worldwide Operations

Giovani Twigge

 49 2010 Corporate Vice President - Worldwide Human Resources

Conan Deady

 51 2013 Corporate Vice President, Secretary

George Fennell

 44 2011 Corporate Vice President - Companion Animal Group

Ali Naqui

 59 2012 Corporate Vice President - Asia Pacific and Latin America Operations and Water Line of Business

James Polewaczyk

 49 2012 Corporate Vice President - CAG Reference Laboratories and Telemedicine Line of Business

William End

 65 Lead Independent Director

Thomas Craig

 58 1999 Independent Director

Rebecca Henderson

 52 2003 Independent Director

Barry Johnson

 69 2006 Independent Director

Brian McKeon

 50 2003 Independent Director

Robert Murray

 72 2005 Independent Director

M. Anne Szostak

 62 2012 Independent Director
» Insider Trading

Biographies

Name Description

Jonathan Ayers

 Mr. Jonathan W. Ayers is Chairman of the Board, President, Chief Executive Officer of IDEXX Laboratories Inc., since January 24, 2002. Prior to joining IDEXX, Mr. Ayers held various positions at United Technologies Corporation and its business unit Carrier Corporation. From 1999 to 2001, Mr. Ayers was President of Carrier Corporation. From 1997 to 1999, Mr. Ayers was President of Carrier Asia Pacific Operations, and from 1995 to 1997, Mr. Ayers was Vice President, Strategic Planning at United Technologies. Prior to joining United Technologies, from 1986 to 1995, Mr. Ayers held various positions at Morgan Stanley & Co. in mergers and acquisitions and corporate finance. Mr. Ayers worked as a strategy consultant for Bain & Company from 1983 to 1986 and was in the field sales organization of IBM’s Data Processing Division from 1978 to 1981. Mr. Ayers holds an undergraduate degree in molecular biophysics and biochemistry from Yale University and graduated from Harvard Business School in 1983.

Willard Blanche

 Mr. Willard R. Blanche Jr. is Acting Chief Financial Officer, Vice President - Finance of IDEXX Laboratories, Inc. He was appointed as Acting Chief Financial Officer of the Company effective May 10, 2013. He has served as the Company’s Vice President of Finance since January 2013. Prior to that, Mr. Blanche held a series of roles within the Company’s finance organization, including Senior Director of Finance from July 2012 to January 2013 and Director of Finance for the Company’s reference laboratories line of business from November 2011 to July 2012. Before joining the Company in 2007, Mr. Blanche held various positions of increasing responsibility with PricewaterhouseCoopers LLP from 1996 to 2007. Mr. Blanche received a bachelor’s degree in accounting from Bryant University.

William Brown

 Dr. William E. Brown, III, Ph.D., is Executive Vice President, Chief Scientific Officer of IDEXX Laboratories Inc. Dr. Brown has been Executive Vice President, overseeing Research and Development, of the Company since July 2012. In December 2008, he joined IDEXX as Corporate Vice President, and was promoted to Chief Scientific Officer of the Company in March 2010. Prior to joining IDEXX, from 1982 to 2007, Dr. Brown held various positions at Abbott Laboratories, Inc., a broad-based healthcare company that manufactures and markets pharmaceuticals, medical products, and diagnostics, most recently as Corporate Officer and Divisional Vice President of R&D, Assays and Instrument Systems for the Diagnostic Division.

Jeffrey Fiarman

 Mr. Jeffrey A. Fiarman has been appointed as Executive Vice President, General Counsel of IDEXX Laboratories, Inc. effective May 1, 2013. Prior to joining IDEXX, Fiarman was Executive Vice President and General Counsel at Weight Watchers International, Inc. for seven years where he provided oversight for a broad range of legal, regulatory, risk management, intellectual property and insurance functions.

Jay Mazelsky

 Mr. Jay Mazelsky is Executive Vice President of IDEXX Laboratories Inc., since August 2012. He oversees the Companion Animal Group Customer Facing Organization in North America; the IDEXX VetLab® in-house diagnostics, Digital Radiography and Computer Systems lines of business; the Pet Health Network® Pro offering and the VetConnect® PLUS and Integrated Practice strategies. Prior to joining the Company, Mr. Mazelsky was a Senior Vice President and General Manager from 2010 to 2012 of Computed Tomography, Nuclear Medicine and Radiation Therapy Planning at Philips Healthcare (“Philips”), a subsidiary of Royal Philips Electronics, the Netherlands, a healthcare, lifestyle and lighting technologies company. Previously he held a series of other leadership roles with increasing responsibilities during his tenure at Philips beginning in 2001. Prior to joining Philips, Mr. Mazelsky was at Agilent Technologies Inc., a technology company, where he was an Executive in Charge from 2000 to 2002 of the integration of Agilent’s Healthcare Group into Philips. He also served as a General Manager of the Medical Consumables Business Unit from 1997 to 2000 at Agilent Technologies. From 1988 to 1996, he was in a number of roles at Hewlett Packard Corporation, a technology company, in finance, marketing and business planning.

Johnny Powers

 Dr. Johnny D. Powers, Ph.D., is Executive Vice President of IDEXX Laboratories Inc., since July 20, 2012. He overseeing IDEXX Reference Laboratories, Telemedicine, Rapid Assay, Bioresearch and Worldwide Operations. He joined IDEXX as Corporate Vice President in February 2009 the Company’s worldwide reference laboratories business. Prior to joining the Company, Dr. Powers was Vice President responsible for the Cancer Diagnostics business of Becton, Dickinson and Company, a medical technology company, from 2007 to 2008. Dr. Powers joined Becton, Dickinson and Company as a result of its acquisition in 2006 of TriPath Imaging Inc., a molecular diagnostics-based cancer diagnostics company, where he held various positions from 2001 to 2007, including Vice President of Worldwide Operations and most recently served as President of the TriPath Oncology business unit. From 1996 to 2001, Dr. Powers was employed by Ventana Medical Systems, Inc., a tissue-based cancer diagnostics company, where he held various positions, including Vice President and General Manager of the Anatomical Pathology business and Vice President and General Manager of Worldwide Operations. From 1989 to 1996, Dr. Powers was employed by Organon Teknika Corporation, a medical diagnostics company, in various technical management roles.

Michael Williams

 Dr. Michael J. Williams, Ph.D., is Executive Vice President of IDEXX Laboratories Inc. He oversees the Company’s international operations, and the Livestock and Poultry Diagnostics, Dairy, Water and OPTI Medical Systems lines of business. He was Corporate Vice President, IDEXX VetLab® in-house diagnostics, of the Company from September 2006 to July 2012 and General Manager of the IDEXX VetLab® in-house diagnostics line of business from 2004 to 2012. Dr. Williams has also overseen the OPTI Medical Systems business since its acquisition in January 2007. Dr. Williams was Vice President and General Manager of the Company’s chemistry instruments and consumables business from 2003 to 2004. Prior to joining the Company in 2003, Dr. Williams was a healthcare strategy consultant at McKinsey & Company, a management consulting firm, from 1995 to 2002, and a senior research associate at the Scripps Research Institute, a non-profit research organization, from 1992 to 1995.

Daniel Meyaard

 Mr. Daniel V. Meyaard is Corporate Vice President - Worldwide Operations of IDEXX Laboratories Inc., since September 2009. Mr. Meyaard leads the Company’s worldwide operations function, including supply chain management, instrument and reagent manufacturing, quality assurance, facilities and operational excellence. Prior to joining the Company, from 1980 to 2009, Mr. Meyaard held various positions at multiple divisions of Siemens Healthcare Diagnostics, a clinical diagnostics company, and its predecessors, most recently as Vice President of Global Instrument Manufacturing for Siemens Medical Solutions Diagnostics.

Giovani Twigge

 Mr. Giovani Twigge is Corporate Vice President - Worldwide Human Resources of IDEXX Laboratories Inc., since August 2010. Before joining IDEXX, from 1999 to 2010, Mr. Twigge held various human resources leadership positions at Abbott Laboratories, Inc., a broad-based healthcare company that manufactures and markets pharmaceuticals, medical products, and diagnostics. Most recently Mr. Twigge was Divisional Vice President, HR, for Abbott Diagnostics. Prior to that, he served as Divisional Vice President, HR, for Abbott Nutrition International and as Regional HR Director for a number of international operations including those in Europe, Latin America/Canada and the Middle East.

Conan Deady

 Mr. Conan R. Deady is Corporate Vice President, Secretary of IDEXX Laboratories Inc. He resigned as General Counsel of the company effective May 1, 2013. Mr. Deady has been Corporate Vice President and General Counsel of the Company since 1999 and has been the Company’s business development activities since April 2005 and its regulatory function since October 2008. Mr. Deady was Deputy General Counsel of the Company from 1997 to 1999. Before joining the Company in 1997, Mr. Deady was Deputy General Counsel of Thermo Electron Corporation (now Thermo Fisher Scientific Inc.), a provider of analytical and laboratory products and services. Previously, Mr. Deady was a partner at Hale and Dorr LLP (now Wilmer Cutler Pickering Hale and Dorr LLP).

George Fennell

 Mr. George J. Fennell is Corporate Vice President - Companion Animal Group of IDEXX Laboratories Inc., since June 2011. Mr. Fennell came to IDEXX from Pfizer Animal Health, a division of Pfizer Inc., the world’s research-based pharmaceutical company, where in April 2003 he began as head of marketing for the companion animal business. He then served as vice president of the U.S. Companion Animal Division from 2005 through 2010, and from January 2011, was Vice President, Pfizer Animal Genetics, Diagnostics and Aquaculture. Before his tenure at Pfizer, he held a series of sales, marketing and operational roles in the crop sciences business for American Cyanamid and BASF, diversified chemical companies.

Ali Naqui

 Dr. Ali Naqui, Ph.D., is Corporate Vice President - Asia Pacific and Latin America Operations and Water Line of Business of IDEXX Laboratories Inc. Dr. Naqui has been Corporate Vice President of the Company since January 2006, when he assumed oversight of IDEXX’s Asia Pacific and Latin America operations. Since July 2012, he has also led the Water line of business, which he previously led from 1997 to 2007. From 2007 to 2012, Dr. Naqui also oversaw the Company’s Europe, Middle East and Africa commercial operations. He was General Manager of the Water business from September 1997 to January 2000, and Director of Research and Development from February 1993 to September 1997. Dr. Naqui joined the Company in 1993 as a result of the Company’s acquisition of Environetics, the original manufacturer of the Colilert® water testing product line, where he was the Director of Research and Development. Prior to joining Environetics, he was a research and development manager with Becton, Dickinson and Company, a medical technology company.

James Polewaczyk

 Mr. James F. Polewaczyk is Corporate Vice President - CAG Reference Laboratories and Telemedicine Line of Business of IDEXX Laboratories Inc. Mr. Polewaczyk joined IDEXX as Corporate Vice President in February 2007 and since July 2012 has led the Company’s CAG Reference Laboratories and Telemedicine lines of business. From 2007 to 2012, Mr. Polewaczyk led the Company’s Rapid Assay, Digital Imaging and Telemedicine lines of business. Before joining IDEXX, Mr. Polewaczyk was employed from 2001 to 2006 at Philips Medical Systems, a subsidiary of Royal Philips Electronics, the Netherlands, a healthcare, lifestyle and lighting technologies company, as General Manager of their Medical Consumables and Sensors Business. Prior to that, Mr. Polewaczyk spent 15 years at Hewlett-Packard Corporation, a technology company, in a variety of senior marketing and medical technology product development roles.

William End

 Mr. William T. End is Lead Independent Director of IDEXX Laboratories Inc. Mr. End was Chairman and Chief Executive Officer of Cornerstone Brands, Inc., a privately-held catalog retailer, from 1995 to 2001, and Executive Chairman of that company from 2001 until his retirement in 2002. In these executive roles Mr. End was responsible for all corporate functions as well as Board function and activity. Prior to joining Cornerstone Brands, Mr. End held various positions at Land’s End, Inc. from 1991 to 1995, including President and Chief Executive Officer. From 1975 to 1991, Mr. End held various positions at L.L. Bean, Inc., a privately-held catalog retailer, including Executive Vice President and Chief Marketing Officer. Mr. End has executive experience with a particular focus on marketing and product development. Mr. End was a director and chairman of Eddie Bauer Holdings, Inc., a catalog retailer, from 2005 to 2009, a director of New England Business Services, Inc., a business to business direct marketing company, from 2000 to 2003, Hannaford Bros. Co., a supermarket and grocery retailer, from 1995 to 2000, and Land’s End, Inc., a catalog retailer, from 1990 to 1995. He also has been a director of several non-public companies. In these capacities, Mr. End has developed experience with board function and corporate governance. Mr. End received a B.S.B.A. from Boston College and earned an M.B.A. from Harvard Business School.

Thomas Craig

 Mr. Thomas Craig is Independent Director of IDEXX Laboratories Inc., since December 1999. Mr. Craig is currently Chairman and CEO of Shockwave International, a firm whose mission is to work with principal investors to help package deals by combining capital, ideas, human assets, and advisory services. Mr. Craig co-founded and was a Partner at Monitor Group, a global management consulting firm, until May 2012 when he retired after 29 years. Mr. Craig has broad international and industry experience. He has worked in over 70 countries on six continents and has led over 400 projects over the past 33 years for Fortune 500 companies and their international equivalents, startups, and at the highest levels of government. Earlier in his career, Mr. Craig served on the research faculty of the Harvard Business School. He also worked in the field of litigative economics. He has been active in delivering various executive education programs and leadership development initiatives. Mr. Craig received an A.B. from Princeton University and an M.B.A. with high distinction from Harvard Business School.

Rebecca Henderson

 Dr. Rebecca M. Henderson, Ph.D., is Independent Director of IDEXX Laboratories Inc., since July 21, 2003. Dr. Henderson joined Harvard Business School in July 2009 as the Senator John Heinz Professor of Environmental Management where she specializes in strategy and organizational change. In September 2011, Dr. Henderson received Harvard University’s highest faculty honor when she was named a Harvard University Professor. From 1998 to 2009, Dr. Henderson served as the Eastman Kodak Professor of Management at the Sloan School of the Massachusetts Institute of Technology. Dr. Henderson also has board oversight and corporate governance experience as a director since July 2009 of Amgen Inc., a publicly-traded human therapeutics company in the biotechnology industry, and as a director of several private company and non-profit organization boards. Dr. Henderson also has been a research fellow at the National Bureau of Economic Research since 1995. Dr. Henderson holds an undergraduate degree from the Massachusetts Institute of Technology and a Ph.D. in business economics from Harvard University. Dr. Henderson has worked with numerous Fortune 500 companies on growth strategies related to innovation.

Barry Johnson

 Dr. Barry C. Johnson, Ph.D., is Independent Director of IDEXX Laboratories Inc., since March 16, 2006. Dr. Johnson served as Dean, College of Engineering, Villanova University, from August 2002 until his retirement in May 2006. From July 2000 to April 2002, he served as Senior Vice President and Chief Technology Officer of Honeywell International, Inc., a worldwide diversified technology and manufacturing company with sales in 2001 exceeding $23 billion. As Chief Technology Officer, Dr. Johnson was responsible for setting the strategic direction and prioritization of Honeywell’s research and development organization, which was supported by a global network of more than 15,000 engineers, scientists and researchers. Prior to Honeywell, Dr. Johnson served in several roles beginning in 1976 at Motorola, Inc., providing integrated communications solutions, including Corporate Vice President and Chief Technology Officer for that company’s Semiconductor Product Sector. Dr. Johnson also has board oversight and corporate governance experience from his service as a director since September 2005 of Rockwell Automation, Inc., a publicly-traded global automation solutions company, and as a director since August 2003 of Cytec Industries, Inc., a publicly-traded global specialty chemicals and materials company. Dr. Johnson earned a B.M.E. (Bachelor of Mechanical Engineering) from Villanova University and holds a Ph.D. and M.S. in metallurgical engineering and materials science from Carnegie-Mellon University. He also completed a three-year advanced business administration program through Arizona State University’s College of Business Administration.

Brian McKeon

 Mr. Brian P. McKeon is Independent Director of IDEXX Laboratories Inc., since July 21, 2003. Mr. McKeon has served as Executive Vice President and Chief Financial Officer for Iron Mountain Incorporated since April 2007. Iron Mountain is a publicly-traded provider of information protection and storage services worldwide with over $3 billion in revenues during 2011. Mr. McKeon was also Executive Vice President and Chief Financial Officer of The Timberland Company from March 2000 to April 2007. Timberland is a publicly-traded provider of premium outdoor footwear, apparel and accessories that had over $1.5 billion in revenues in 2006, the last full fiscal year of Mr. McKeon’s tenure. From 1991 to 2000, Mr. McKeon held several finance and strategic planning positions with PepsiCo Inc., serving most recently as Vice President, Finance at Pepsi-Cola, North America. Prior to joining PepsiCo, Mr. McKeon worked as a strategy consultant with the Alliance Consulting group and as an auditor with Coopers & Lybrand. Mr. McKeon earned a B.S. from the University of Connecticut and received an M.B.A. from Harvard University. As a CPA with nearly 20 years of experience as a finance executive.

Robert Murray

 Mr. Robert J. Murray is Independent Director of IDEXX Laboratories Inc., since February 24, 2005. Mr. Murray served as Chairman of the Board and Chief Executive Officer of New England Business Service, Inc., or NEBS, from 1995 until his retirement in 2004. NEBS was a publicly-traded business to business direct marketing company and had over $500 million in sales during the last fiscal year prior to Mr. Murray’s retirement. As the chief executive officer of NEBS, Mr. Murray was responsible for all aspects of the business. Mr. Murray held various executive positions at The Gillette Company from 1961 to 1995, including Executive Vice President, North Atlantic Group from 1991 to 1995, and Chairman of the Board of Management of Braun AG, a subsidiary of Gillette headquartered in Germany, from 1985 to 1990. In these positions, Mr. Murray developed substantial experience in international business operations and led all aspects of the business for these divisions. Mr. Murray has served as a director for the following public companies during the years indicated: The Hanover Insurance Group, Inc., a property and casualty insurance company (since 1996); LoJack Corporation, an automobile security system manufacturer (since 1992); Tupperware Brands Corporation, a consumer-direct seller of personal and household products (since 2004); and Delhaize Group, an international food retailer based in Belgium (from 2001 to 2012). Mr. Murray received a B.S and B.A. from Boston College and an M.B.A. from Northeastern University and he completed Harvard Business School’s Advanced Management Program.

M. Anne Szostak

 Ms. M. Anne Szostak has been appointed as Independent Director of IDEXX Laboratories, Inc., effective July 10, 2012. In 2004, Ms. Szostak founded Szostak Partners, LLC, an executive coaching and human resources consulting firm, for which she continues to serve as Chief Executive Officer. Before founding Szostak Partners, Ms. Szostak had a 31-year career with Fleet/Boston Financial Group (now Bank of America), a Fortune 100 publicly-traded, diversified financial services company. During her tenure at Fleet/Boston, she gained operational and staffing management responsibilities, including as Chairman, President and Chief Executive Officer of Fleet-Maine, Chairman and Chief Executive Officer of Fleet Bank-Rhode Island, and Corporate Executive Vice President and Chief Human Resources Officer of FleetBoston Financial Group. Ms. Szostak served or has served as a director of the following public companies during the years indicated: Tupperware Brands Corporation, a consumer-direct seller of personal and household items (since 2000); Belo Corp., an owner and operator of television stations and their associated Web sites (since 2004); ChoicePoint Corporation, a data aggregation company (from 2005 until the company’s sale in 2008); SFN Group, a staffing solutions provider (from 2005 until the company’s sale in 2011); and Dr Pepper Snapple Group, Inc., a beverage manufacturer, bottler and distributor (since 2008). Ms. Szostak also serves on the boards of several local, regional and national non-profit organizations. Ms. Szostak holds an undergraduate degree from Colby College, and she has completed several executive education programs at Harvard Business School.

Insider Trading

Name Shares Traded Price

MURRAY ROBERT J

 369 $0.00

NAQUI ALI

 12,961 $87.00

NAQUI ALI

 14,779 $56.95

CRAIG THOMAS

 199 $87.96

TWIGGE GIOVANI

 212 $77.59

TWIGGE GIOVANI

 5,410 $57.14

TWIGGE GIOVANI

 7,055 $92.13

DEADY CONAN R

 3,609 $53.31

DEADY CONAN R

 2 $34.37

DEADY CONAN R

 2,419 $87.42

DEADY CONAN R

 6,030 $91.72

RAINES MERILEE

 4,527 $34.37

RAINES MERILEE

 4,433 $56.95

RAINES MERILEE

 4,060 $53.31

RAINES MERILEE

 2,851 $77.59

AYERS JONATHAN W

 1,200 $0.00

TWIGGE GIOVANI

 137 $91.68

WILLIAMS MICHAEL J

 258 $0.00

DEADY CONAN R

 363 $0.00

AYERS JONATHAN W

 2,208 $91.68

DEADY CONAN R

 496 $91.68

DEADY CONAN R

 243 $0.00

AYERS JONATHAN W

 1,200 $0.00

DEADY CONAN R

 3,449 $56.95

AYERS JONATHAN W

 1,200 $0.00
» Full list on Insider Trading
Search Stocks